Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Immunome (IMNM) Asset Utilization Ratio (2023 - 2025)

Historic Asset Utilization Ratio for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to 0.03.

  • Immunome's Asset Utilization Ratio fell 1126.92% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year decrease of 1126.92%. This contributed to the annual value of 0.05 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Immunome's Asset Utilization Ratio stood at 0.03, which was down 1126.92% from 0.04 recorded in Q2 2025.
  • In the past 5 years, Immunome's Asset Utilization Ratio ranged from a high of 0.12 in Q4 2023 and a low of 0.03 during Q3 2025
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.04 (2024), whereas its average is 0.05.
  • Per our database at Business Quant, Immunome's Asset Utilization Ratio tumbled by 6864.33% in 2024 and then soared by 1253.33% in 2025.
  • Immunome's Asset Utilization Ratio (Quarter) stood at 0.12 in 2023, then crashed by 68.64% to 0.04 in 2024, then fell by 10.65% to 0.03 in 2025.
  • Its Asset Utilization Ratio was 0.03 in Q3 2025, compared to 0.04 in Q2 2025 and 0.04 in Q1 2025.